Evidence map›Paper›PMID 36819612›Full record

ReviewRegenerative therapy2023

Advances in tooth agenesis and tooth regeneration.

V Ravi, A Murashima-Suginami, H Kiso, Y Tokita, C L Huang, K Bessho, J Takagi, M Sugai, Y Tabata, K Takahashi

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Regenerative therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

V RaviToregem BioPharma Inc., Kyoto, Japan.
A Murashima-SuginamiToregem BioPharma Inc., Kyoto, Japan.
H KisoToregem BioPharma Inc., Kyoto, Japan.
Y TokitaDepartment of Disease Model, Institute for Developmental Research, Aichi Human Service Center, Kasugai, Aichi, Japan.
C L HuangDepartment of ThoracicSurgery, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.
K BesshoDepartment of Oral and Maxillofacial Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
J TakagiLaboratory of Protein Synthesis and Expression, Institute for Protein Research, Osaka University, Osaka, Japan.
M SugaiDepartment of Molecular Genetics, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Y TabataLaboratory of Biomaterials, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
K TakahashiToregem BioPharma Inc., Kyoto, Japan.
Kitano Hospital · JPKyoto University · JPAichi Human Service Center · JPOsaka University · JPUniversity of Fukui · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lack of treatment options for congenital (0.1%) and partial (10%) tooth anomalies highlights the need to develop innovative strategies. Over two decades of dedicated research have led to breakthroughs in the treatment of congenital and acquired tooth loss. We revealed that by inactivating

Indexed as

BMP, bone morphogenetic proteinCEBPB, CCAAT enhancer binding protein betaCongenital tooth agenesisEDAEDA, Ectodysplasin ATooth regenerationUSAG-1 neutralizing antibodyUSAG-1, Uterine sensitization associated gene-1

Identifiers

PMID36819612
PMCPMC9931762
OpenAlexW4319081325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.